Bio-Rad Laboratories Quick Ratio 2010-2025 | BIO
Historical quick ratio values for Bio-Rad Laboratories (BIO) over the last 10 years.
| Bio-Rad Laboratories Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2025-03-31 | $2.25B | $0.51B | 4.43 |
| 2024-12-31 | $2.27B | $0.47B | 4.85 |
| 2024-09-30 | $2.25B | $0.50B | 4.52 |
| 2024-06-30 | $2.25B | $0.49B | 4.63 |
| 2024-03-31 | $2.28B | $0.47B | 4.89 |
| 2023-12-31 | $2.27B | $0.52B | 4.34 |
| 2023-09-30 | $2.37B | $0.56B | 4.25 |
| 2023-06-30 | $2.36B | $0.58B | 4.06 |
| 2023-03-31 | $2.52B | $0.59B | 4.28 |
| 2022-12-31 | $2.44B | $0.57B | 4.29 |
| 2022-09-30 | $2.45B | $0.57B | 4.30 |
| 2022-06-30 | $2.59B | $0.61B | 4.22 |
| 2022-03-31 | $2.70B | $0.65B | 4.16 |
| 2021-12-31 | $1.42B | $0.68B | 2.08 |
| 2021-09-30 | $1.88B | $0.65B | 2.89 |
| 2021-06-30 | $1.69B | $0.59B | 2.88 |
| 2021-03-31 | $1.57B | $0.61B | 2.57 |
| 2020-12-31 | $1.52B | $0.63B | 2.40 |
| 2020-09-30 | $1.68B | $0.99B | 1.71 |
| 2020-06-30 | $1.50B | $0.93B | 1.62 |
| 2020-03-31 | $1.53B | $0.87B | 1.76 |
| 2019-12-31 | $1.63B | $0.91B | 1.80 |
| 2019-09-30 | $1.46B | $0.43B | 3.36 |
| 2019-06-30 | $1.50B | $0.45B | 3.36 |
| 2019-03-31 | $1.44B | $0.44B | 3.24 |
| 2018-12-31 | $1.44B | $0.45B | 3.19 |
| 2018-09-30 | $1.43B | $0.45B | 3.16 |
| 2018-06-30 | $1.40B | $0.44B | 3.17 |
| 2018-03-31 | $1.37B | $0.46B | 2.99 |
| 2017-12-31 | $1.38B | $0.50B | 2.75 |
| 2017-09-30 | $1.29B | $0.47B | 2.77 |
| 2017-06-30 | $1.25B | $0.46B | 2.74 |
| 2017-03-31 | $1.17B | $0.41B | 2.88 |
| 2016-12-31 | $1.32B | $0.47B | 2.80 |
| 2016-09-30 | $1.29B | $0.44B | 2.92 |
| 2016-06-30 | $1.26B | $0.41B | 3.08 |
| 2016-03-31 | $1.24B | $0.40B | 3.10 |
| 2015-12-31 | $1.29B | $0.44B | 2.92 |
| 2015-09-30 | $1.28B | $0.44B | 2.95 |
| 2015-06-30 | $1.24B | $0.40B | 3.07 |
| 2015-03-31 | $1.22B | $0.42B | 2.94 |
| 2014-12-31 | $1.25B | $0.45B | 2.79 |
| 2014-09-30 | $1.25B | $0.50B | 2.48 |
| 2014-06-30 | $1.25B | $0.48B | 2.60 |
| 2014-03-31 | $1.25B | $0.48B | 2.60 |
| 2013-12-31 | $1.24B | $0.49B | 2.55 |
| 2013-09-30 | $1.15B | $0.46B | 2.49 |
| 2013-06-30 | $1.42B | $0.43B | 3.29 |
| 2013-03-31 | $1.40B | $0.45B | 3.13 |
| 2012-12-31 | $1.48B | $0.47B | 3.14 |
| 2012-09-30 | $1.39B | $0.43B | 3.20 |
| 2012-06-30 | $1.36B | $0.42B | 3.26 |
| 2012-03-31 | $1.35B | $0.44B | 3.05 |
| 2011-12-31 | $1.37B | $0.46B | 2.97 |
| 2011-09-30 | $1.43B | $0.42B | 3.45 |
| 2011-06-30 | $1.44B | $0.44B | 3.25 |
| 2011-03-31 | $1.37B | $0.43B | 3.20 |
| 2010-12-31 | $1.58B | $0.67B | 2.37 |
| 2010-09-30 | $1.25B | $0.41B | 3.04 |
| 2010-06-30 | $1.19B | $0.39B | 3.04 |
| 2010-03-31 | $1.16B | $0.40B | 2.92 |
| 2009-12-31 | $1.21B | $0.42B | 2.89 |
| 2009-09-30 | $1.12B | $0.42B | 2.69 |
| 2009-06-30 | $1.02B | $0.38B | 2.66 |
| 2009-03-31 | $0.68B | $0.36B | 1.91 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.273B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.364B | 28.06 |
| Stryker (SYK) | United States | $146.969B | 30.73 |
| Boston Scientific (BSX) | United States | $146.968B | 36.79 |
| EssilorLuxottica (ESLOY) | France | $131.277B | 0.00 |
| Medtronic (MDT) | Ireland | $112.813B | 15.99 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.710B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.016B | 27.92 |
| ResMed (RMD) | United States | $37.047B | 27.83 |
| Agilent Technologies (A) | United States | $34.235B | 22.32 |
| GE HealthCare Technologies (GEHC) | United States | $33.847B | 16.07 |
| Terumo (TRUMY) | Japan | $26.946B | 35.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.399B | 16.10 |
| Insulet (PODD) | United States | $21.023B | 82.52 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.780B | 12.06 |
| Baxter (BAX) | United States | $16.278B | 12.15 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.165B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $4.281B | 19.13 |
| Perrigo (PRGO) | Ireland | $3.794B | 9.62 |
| Haemonetics (HAE) | United States | $3.466B | 15.79 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.367B | 24.83 |
| Envista Holdings (NVST) | United States | $3.244B | 26.96 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.091B | 14.38 |
| LeMaitre Vascular (LMAT) | United States | $1.890B | 42.24 |
| AtriCure (ATRC) | United States | $1.653B | 0.00 |
| Acuren (TIC) | United States | $1.314B | 0.00 |
| Neogen (NEOG) | United States | $1.268B | 16.22 |
| AdaptHealth (AHCO) | United States | $1.190B | 12.08 |
| BioLife Solutions (BLFS) | United States | $1.136B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.063B | 23.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.053B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.987B | 12.61 |
| InMode (INMD) | Israel | $0.920B | 9.27 |
| CeriBell (CBLL) | United States | $0.640B | 0.00 |
| Evolus (EOLS) | United States | $0.636B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.634B | 0.00 |
| Owens & Minor (OMI) | United States | $0.629B | 5.22 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.550B | 0.00 |
| Valneva SE (VALN) | France | $0.535B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.422B | 0.00 |
| Surmodics (SRDX) | United States | $0.418B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.367B | 13.50 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.334B | 59.50 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.283B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.276B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.00 |
| ZimVie (ZIMV) | United States | $0.266B | 12.09 |
| Sanara MedTech (SMTI) | United States | $0.265B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.264B | 0.00 |
| Quanterix (QTRX) | United States | $0.256B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.253B | 0.00 |
| Omeros (OMER) | United States | $0.227B | 0.00 |
| Biote (BTMD) | United States | $0.227B | 6.37 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Brainsway (BWAY) | Israel | $0.216B | 57.30 |
| TriSalus Life Sciences (TLSI) | United States | $0.211B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.16 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| MacroGenics (MGNX) | United States | $0.112B | 0.00 |
| Jin Medical (ZJYL) | China | $0.105B | 0.00 |
| Veru (VERU) | United States | $0.098B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.88 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.074B | 0.00 |
| Apyx Medical (APYX) | United States | $0.069B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.066B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.43 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |